These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10590330)

  • 1. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert.
    Swayne DE; Garcia M; Beck JR; Kinney N; Suarez DL
    Vaccine; 2000 Jan; 18(11-12):1088-95. PubMed ID: 10590330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
    Bertran K; Criado MF; Lee DH; Killmaster L; Sá E Silva M; Lucio E; Widener J; Pritchard N; Atkins E; Mebatsion T; Swayne DE
    Vaccine; 2020 Feb; 38(6):1526-1534. PubMed ID: 31862196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
    Qiao CL; Yu KZ; Jiang YP; Jia YQ; Tian GB; Liu M; Deng GH; Wang XR; Meng QW; Tang XY
    Avian Pathol; 2003 Feb; 32(1):25-32. PubMed ID: 12745375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
    Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine.
    Swayne DE; Beck JR; Kinney N
    Avian Dis; 2000; 44(1):132-7. PubMed ID: 10737653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus.
    Swayne DE; Beck JR; Mickle TR
    Avian Dis; 1997; 41(4):910-22. PubMed ID: 9454926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years.
    Swayne DE; Perdue ML; Beck JR; Garcia M; Suarez DL
    Vet Microbiol; 2000 May; 74(1-2):165-72. PubMed ID: 10799788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin.
    Boyle DB; Selleck P; Heine HG
    Aust Vet J; 2000 Jan; 78(1):44-8. PubMed ID: 10736685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses.
    Beard CW; Schnitzlein WM; Tripathy DN
    Avian Dis; 1991; 35(2):356-9. PubMed ID: 1649592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
    Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
    Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
    Bertran K; Kassa A; Criado MF; Nuñez IA; Lee DH; Killmaster L; Sá E Silva M; Ross TM; Mebatsion T; Pritchard N; Swayne DE
    Vaccine; 2021 Apr; 39(14):1933-1942. PubMed ID: 33715903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
    Steensels M; Van Borm S; Lambrecht B; De Vriese J; Le Gros FX; Bublot M; van den Berg T
    Avian Dis; 2007 Mar; 51(1 Suppl):325-31. PubMed ID: 17494576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks.
    Qian C; Chen S; Ding P; Chai M; Xu C; Gan J; Peng D; Liu X
    Vaccine; 2012 Sep; 30(44):6279-86. PubMed ID: 22902682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    Niqueux E; Guionie O; Amelot M; Jestin V
    Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.